-

Shareholder Alert: Robbins LLP Announces FirstEnergy Corp. (FE) Accused of Misleading Shareholders

SAN DIEGO & AKRON, Ohio--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of FirstEnergy Corp. (NYSE: FE) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between February 21, 2017 and July 21, 2020. FirstEnergy generates, transmits, and distributes electricity in the United States.

If you suffered a loss as a result of FirstEnergy's misconduct, click here.

FirstEnergy Corp. (FE) Accused of Engaging in an Illicit Bribery Scheme

According to the complaint, at the end of fiscal 2016, FirstEnergy reported a weak energy market, poor forecast demand, and hundreds of millions of dollars in losses. To alleviate investor concern, FirstEnergy stated in its annual report for 2016 that it intended to pursue "legislative or regulatory solutions" to remedy its dismal financial prospects. However, FirstEnergy failed to disclose that these solutions included an illicit campaign that funneled tens of millions of dollars to state lawmakers, including Ohio House Speaker Larry Householder, issuing misleading messages on media platforms, and illegally thwarting a citizen's ballot initiative to secure the votes for passage of Ohio House Bill 6 ("HB6"), which provided a $1.3 billion ratepayer-funded bailout to keep FirstEnergy's nuclear facilities in operation. On July 21, 2020, federal agents announced the arrest of Householder and four other individuals, including a prominent FirstEnergy lobbyist in connection with a $60 million racketeering and bribery scheme. The criminal complaint described FirstEnergy's extensive bribery scheme and corruptive tactics to ensure the passage of HB6 as "the largest bribery, money-laundering scheme" in Ohio history. On this news, the price of FirstEnergy stock plummeted, trading as low as $22.85 per share on July 22, 2020, representing a 45% decline from its closing price of $41.26 per share on July 20, 2020.

FirstEnergy Corp. (FE) Shareholders Have Options

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against FirstEnergy settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Regencell Bioscience Holdings Limited Class Action Reminder - Robbins LLP Encourages RGC Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...

POET Technologies Inc. Class Action Reminder - Robbins LLP Encourages POET Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POET Technologies Inc. (NASDAQ: POET) securities between April 1, 2026 and 8:57 A.M. ET on April 27, 2026. POET Technologies describes itself as a "design and development company offering photonic integrated packaging solutions based on the POET Optical Interposer™, a novel platform that allows the seamless integration of electronic and photoni...

Immutep Limited Class Action Reminder - Robbins LLP Encourages IMMP Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating Allegations that Immutep Limited (IMMP) Misled Investors Regarding the Viability and Efficacy of its Drug CandidateOn May 5, 2026, a class action was filed on behalf of all investors who purchased or otherwise acquired Immutep Limited American Depository Receipts (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026. Immutep is an Australian-based biotechnology company focused on developing Lymphocyte Activation Gene-3 (LAG-3) related i...
Back to Newsroom